In order to explore the potential differences in serum CHI3L1 levels among patients with liver fibrosis of different etiologies, we compared the CHI3L1 levels between patients with autoimmune liver diseases and CHB patients. This evidence concerns the gene CHI3L1 and Hepatic fibrosis.